SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Chris W. who wrote (2059)4/8/1999 3:16:00 PM
From: Steve Harmon  Respond to of 2742
 
Are we going to hear that word "ENHANCED" again? We the shareholders(People that actually bought Cistron stock) have heard that word again and again and again and again....



To: Chris W. who wrote (2059)4/11/1999 10:26:00 PM
From: Steve Harmon  Respond to of 2742
 
Genome gets $1,000,000 if they sell Cistron for $1.



To: Chris W. who wrote (2059)4/23/1999 2:03:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Rhone Poulenc recently bought 1.3 million shares of Cistron at 75 cent a share.



To: Chris W. who wrote (2059)4/23/1999 2:10:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
There is a line of small and micro-cap medical device and biotech companies which would pay a 20-30% premium for just Cistron's cash or 70 cent a share!

Current bid>>> .20


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News